Last mentioned: Mar 17, 2026
Regulatory Implementation
Effective date for the first wave of state-level ADAP regulatory changes and income threshold adjustments.
State Announcements
Multiple states officially announce new eligibility restrictions and the implementation of waitlist protocols.
New Limits Reported
States begin implementing restrictive eligibility and waitlists for drug assistance programs.
Federal Guidance
HRSA issues guidance on state flexibility for utilizing Ryan White Part B funds amid rising drug costs.
Budget Proposals
Initial state budget drafts suggest significant shortfalls in ADAP funding for the 2026 fiscal year.
Fiscal Pressure Mounts
Rising costs of long-acting therapies and expiration of pandemic funding strain state budgets.
Waitlist Peak
National ADAP waitlists reached a record high of over 9,000 individuals following the Great Recession.
Ryan White CARE Act
Federal legislation established to provide a safety net for HIV/AIDS care and treatment.
Several states have begun implementing restrictive eligibility requirements and waitlists for AIDS Drug Assistance Programs (ADAPs), citing budgetary shortfalls and rising medication costs. This shift threatens to reverse years of progress in HIV viral suppression and places significant financial pressure on low-income patients and safety-net providers.
Multiple states are implementing restrictive eligibility criteria and waitlists for AIDS Drug Assistance Programs (ADAPs) as rising medication costs outpace funding. These measures threaten to disrupt treatment for thousands of low-income individuals, potentially reversing years of progress in HIV viral suppression.
Multiple states have begun implementing restrictive eligibility requirements for HIV Drug Assistance Programs (ADAPs) due to budgetary constraints. These regulatory changes are expected to increase compliance burdens for healthcare providers and reshape pharmaceutical procurement strategies.
The Florida Legislature has approved a stopgap bill to restore essential funding to the state's AIDS Drug Assistance Program (ADAP), averting a potential crisis in medication access. This legislative action ensures that thousands of low-income residents living with HIV/AIDS will continue to receive life-saving antiretroviral treatments without interruption.